Online Resources: Take advantage of these helpful links to other informative Web sites.

ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus

Home	CME Center	Clinical Trials	About ACT-HBV^®	Treatment Algorithms and Guidelines	Ask the Experts



	Take advantage of these important HBV-related Internet resources, including professional associations and government Web sites.


	American Association for the Study of Liver Diseases (AASLD) American College of Gastroenterology (ACG) American Gastroenterological Association (AGA) American Hepato-Pancreato-Biliary Association (AHPBA) American Liver Foundation (ALF) American Liver Society (ALS) American Society of Transplantation (AST) Asian Pacific Association for the Study of the Liver (APASL) Canadian Liver Foundation CDC: National Center for Infectious Diseases–Viral Hepatitis Centers for Disease Control and Prevention (CDC) CenterWatch: Clinical Trials Listing Service (Clinical Trials: Hepatitis) Children's Liver Disease Foundation ClinicalTrials.gov (U.S. National Institutes of Health) Conference on Retroviruses and Opportunistic Infections Digestive Disease Week® (DDW) European Association for the Study of the Liver (EASL) Gastroenterology Research Group GastroHep.com Hepatitis B Foundation Hepatitis Foundation International HepNet—The Hepatitis Information Network HIVandHepatitis.com Immunization Action Coalition Infectious Diseases Society of America (IDSA) International Association for the Study of the Liver (IASL) International Association of Surgeons & Gastroenterologists (IASG) International Liver Transplantation Society (ILTS) Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Latino Organization for Liver Awareness (LOLA) LiverTumor.org MedlinePlus® National Cancer Institute (NCI) National Foundation for Infectious Diseases (NFID) North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) World Gastroenterology Organisation (OMGE) World Health Organization (WHO)




		The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.